NCT05883644
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05883644
Title Durvalumab and Tremelimumab as First Line Treatment in Participants With Advanced Hepatocellular Carcinoma (HCC) (SIERRA)
Acronym SIERRA
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU

Facility Status City State Zip Country Details
Research Site La Jolla California 92093 United States Details
Research Site Shreveport Louisiana 71103 United States Details
Research Site Detroit Michigan 48202 United States Details
Research Site Bobigny 93000 France Details
Research Site Clichy 92110 France Details
Research Site Creteil 94010 France Details
Research Site Marseille 13005 France Details
Research Site Rennes 35000 France Details
Research Site Berlin D-13353 Germany Details
Research Site Frankfurt 60488 Germany Details
Research Site Köln 50937 Germany Details
Research Site Lübeck 23538 Germany Details
Research Site Hong Kong 0000 Hong Kong Details
Research Site Shatin 00000 Hong Kong Details
Research Site Milano 20132 Italy Details
Research Site Napoli 80147 Italy Details
Research Site Padova 35128 Italy Details
Research Site Pisa 56126 Italy Details
Research Site Rozzano 20089 Italy Details
Research Site Turin 10128 Italy Details
Research Site Kanazawa-shi 920-8641 Japan Details
Research Site Kashiwa 277-8577 Japan Details
Research Site Matsuyama-city 790-0024 Japan Details
Research Site Musashino-shi 180-8610 Japan Details
Research Site Osakasayama-shi 589-8511 Japan Details
Research Site Yokohama-shi 241-8515 Japan Details
Research Site Gyeonggi-do 13620 Korea, Republic of Details
Research Site Seongnam-si 13496 Korea, Republic of Details
Research Site Seoul 03722 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
Research Site Seoul 06351 Korea, Republic of Details
Research Site Singapore 119228 Singapore Details
Research Site Singapore 169610 Singapore Details
Research Site Singapore 308433 Singapore Details
Research Site Barcelona 8035 Spain Details
Research Site Cordoba 14004 Spain Details
Research Site Madrid 28007 Spain Details
Research Site Madrid 28040 Spain Details
Research Site Pamplona 31008 Spain Details
Research Site Hanoi 100000 Vietnam Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field